Edwards Lifesciences's total assets for Q1 2025 were $13.02B, a decrease of -0.25% from the previous quarter. EW total liabilities were $2.83B for the fiscal quarter, a -5.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.